NCT00032396Unknown2 期
A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration
Control Delivery Systems2 个研究点 分布在 1 个国家开始时间: 2001年11月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 发起方
- 试验地点
- 2
研究概览
简要总结
A study evaluating Retisert in patients with age-related macular degeneration
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 55 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Improving Function in Age-Related Macular DegenerationAge-Related Macular DegenerationNCT00572039Thomas Jefferson University241
终止
2 期
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With RanibizumabAge-Related Macular DegenerationNCT01402544University of California, San Diego20
已完成
不适用
Research on age-related macular degeneration and diabetic complications using non-invasive AGEs measurement equipment.age-related macular degeneration, diabetic retinopathyJPRN-UMIN000010741Shinshu University Graduate School of Medicine, Department of Ophthalmology500
已完成
3 期
Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin TrialAge Related Macular DegenerationNCT00593450University of Pennsylvania1,208
已完成
2 期
Research Study in Patients With Persistent Macular EdemaMacular EdemaRetinal DiseaseUveitis, PosteriorDiabetesDiabetic RetinopathyNCT00035906Allergan315